Putin's $26 Billion Longevity Push: Gene Therapy, Organ Printing, and the Quest to Beat Aging

Russia has launched a sprawling $26 billion state initiative called 'New Health Preservation Technologies' that includes gene therapy, organ printing, mini-pig organ cultivation, and cryotherapy. The program reflects Vladimir Putin's reported fascination with extending human life, reportedly confirmed when he was overheard discussing organ replacement and potential immortality during a 2023 meeting with Chinese leader Xi Jinping. In April, Russian deputy science minister Denis Sekirinsky announced scientists were developing gene-therapy treatments to slow cellular aging. Russian researchers are pursuing bioprinting—3D-printing living tissue—and xenotransplantation, growing human-compatible organs in genetically modified mini-pigs, with ambitions to achieve full human organ replacement by 2030.

The initiative is led by Putin's daughter Maria Vorontsova and physicist Mikhail Kovalchuk, head of the Kurchatov Institute, who argue that science will soon enable continuous repair and replacement of body parts. However, critics including Russian bioprinting pioneer Alexander Ostrovskiy contend that many claims remain aspirational, noting that limited peer-reviewed research has emerged and that international sanctions have isolated Russian scientists. Meanwhile, Russia faces some of the developed world's harshest mortality rates, with average male life expectancy at roughly 68 years—far below the United States and much of Western Europe.